Search research articles
Contact Us
Filters
Showing results (61-70 of 81) with videos related to
Page
of 9
Sort By:
Asia Pacific Allergy
|
November 14, 2019
Continued loss of asthma control following epidemic thunderstorm asthma
Chuan T Foo, Ellen Ly Yee, Alan Young, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
November 16, 2025
Poor diagnostic performance of flow volume loops for detection of inducible laryngeal obstruction/vocal cord dysfunction
Laurence E Ruane, Paul Leong, Garun S Hamilton, et al.
The Journal of Pediatrics
|
June 16, 2022
Longitudinal Natural History of Pediatric Subjects Affected with Mucopolysaccharidosis IIIB
Ilyas Okur, Fatih Ezgu, Roberto Giugliani, et al.
Allergology International : Official Journal of the Japanese Society of Allergology
|
July 1, 2026
Sustained clinical remission and relapse of severe eosinophilic asthma following long-term mepolizumab treatment
Rejoy Sabin Thomas, Dennis Thomas, Vanessa M McDonald, et al.
Internal Medicine Journal
|
September 10, 2021
Patient care standards for primary mitochondrial disease in Australia: an Australian adaptation of the Mitochondrial Medicine Society recommendations
Carolyn M Sue, Shanti Balasubramaniam, Drago Bratkovic, et al.
Allergy
|
September 23, 2018
The 2016 Melbourne thunderstorm asthma epidemic: Risk factors for severe attacks requiring hospital admission
Mark Hew, Joy Lee, Nugroho H Susanto, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
May 27, 2026
A Real-World Controlled Multicentre Study Evaluating the Association Between Benralizumab Therapy and Major Outcomes in Severe Asthma
Dennis Thomas, Vanessa M McDonald, Gijo Thomas, et al.
The European Respiratory Journal
|
March 7, 2020
Mepolizumab effectiveness and identification of super-responders in severe asthma
Erin S Harvey, David Langton, Constance Katelaris, et al.
Respiratory Medicine
|
September 5, 2025
Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry
Erin S Harvey, Yuto Hamada, Sarah A Hiles, et al.
Allergy
|
August 26, 2023
Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients
Dennis Thomas, Vanessa M McDonald, Sean Stevens, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 81) with videos related to
Sort By:
Page
of 9
Asia Pacific Allergy
|
November 14, 2019
Continued loss of asthma control following epidemic thunderstorm asthma
Chuan T Foo, Ellen Ly Yee, Alan Young, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
November 16, 2025
Poor diagnostic performance of flow volume loops for detection of inducible laryngeal obstruction/vocal cord dysfunction
Laurence E Ruane, Paul Leong, Garun S Hamilton, et al.
The Journal of Pediatrics
|
June 16, 2022
Longitudinal Natural History of Pediatric Subjects Affected with Mucopolysaccharidosis IIIB
Ilyas Okur, Fatih Ezgu, Roberto Giugliani, et al.
Allergology International : Official Journal of the Japanese Society of Allergology
|
July 1, 2026
Sustained clinical remission and relapse of severe eosinophilic asthma following long-term mepolizumab treatment
Rejoy Sabin Thomas, Dennis Thomas, Vanessa M McDonald, et al.
Internal Medicine Journal
|
September 10, 2021
Patient care standards for primary mitochondrial disease in Australia: an Australian adaptation of the Mitochondrial Medicine Society recommendations
Carolyn M Sue, Shanti Balasubramaniam, Drago Bratkovic, et al.
Allergy
|
September 23, 2018
The 2016 Melbourne thunderstorm asthma epidemic: Risk factors for severe attacks requiring hospital admission
Mark Hew, Joy Lee, Nugroho H Susanto, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
May 27, 2026
A Real-World Controlled Multicentre Study Evaluating the Association Between Benralizumab Therapy and Major Outcomes in Severe Asthma
Dennis Thomas, Vanessa M McDonald, Gijo Thomas, et al.
The European Respiratory Journal
|
March 7, 2020
Mepolizumab effectiveness and identification of super-responders in severe asthma
Erin S Harvey, David Langton, Constance Katelaris, et al.
Respiratory Medicine
|
September 5, 2025
Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry
Erin S Harvey, Yuto Hamada, Sarah A Hiles, et al.
Allergy
|
August 26, 2023
Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients
Dennis Thomas, Vanessa M McDonald, Sean Stevens, et al.
Page
of 9